Shares in Puma Biotechnology jumped 40% after the FDA trod lightly around doubts about its filing for approval of breast cancer drug neratinib. But the talking points raised ahead of Wednesday’s ...

(Reuters) -A return to growth in the Americas helped Puma meet first-quarter sales forecasts and its order book for the rest of the year was looking "very good", the German sportswear retailer said on ...

German sportswear brand Puma has recorded a jump in first-quarter profits to EUR109m (US$132m) from EUR36m a year earlier, with CEO Bjorn Gulden upbeat about the year ahead despite ongoing uncertainty ...

Investing.com -- Shares of Puma SE (ETR:PUMG) jumped more than 5% on Wednesday after BofA Securities upgraded the German sportswear maker to “neutral” from “underperform” and raised its price ...